1. Home
  2. CORT vs FRHC Comparison

CORT vs FRHC Comparison

Compare CORT & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$114.03

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Freedom Holding Corp.

FRHC

Freedom Holding Corp.

N/A

Current Price

$173.41

Market Cap

10.3B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
FRHC
Founded
1998
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.3B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
CORT
FRHC
Price
$114.03
$173.41
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $141.00
N/A
AVG Volume (30 Days)
★ 815.6K
49.0K
Earning Date
11-03-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.29
EPS
0.09
★ 0.52
Revenue
$761,407,000.00
★ $2,191,291,000.00
Revenue This Year
$50.53
N/A
Revenue Next Year
$48.75
N/A
P/E Ratio
$1,275.83
★ $329.96
Revenue Growth
★ 12.79
6.86
52 Week Low
$28.66
$107.98
52 Week High
$126.38
$178.00

Technical Indicators

Market Signals
Indicator
CORT
FRHC
Relative Strength Index (RSI) 51.85 52.02
Support Level $108.33 $145.61
Resistance Level $124.30 $174.21
Average True Range (ATR) 5.17 4.91
MACD -0.14 -0.39
Stochastic Oscillator 53.19 43.05

Price Performance

Historical Comparison
CORT
FRHC

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About FRHC Freedom Holding Corp.

Freedom Holding Corp is a holding company with reportable segments into the following four segments: Brokerage, Banking, Insurance, and Other. The majority of revenue is from the Banking segment. Banking segment consists of the operations of Freedom Bank KZ and Freedom Bank TJ. Geographically, operates in Kazakhstan, Armenia, Cyprus, the USA, and others, with maximum revenue from Kazakhstan.

Share on Social Networks: